Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India
In addition to its approvals for diabetes, weight loss, and the newly added OSA treatment, tirzepatide is now targeting a significant unmet need in cardiovascular health: heart failure
That's where AestheticsPro comes in
The FDA labels for these specific agents include cardiovascular risk reduction indications, making them preferred agents in patients with type 2 diabetes and atherosclerotic cardiovascular disease, as recommended by ADA/American College of Cardiology consensus guidelines
Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study
But studies suggest that roughly a quarter of the weight loss is actually from muscle, with experts warning this could be dangerous, especially for older people, as it can increase the risk of falls